scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1093/CLINIDS/18.3.273 |
P698 | PubMed publication ID | 8011804 |
P2093 | author name string | Donowitz GR | |
Sable CA | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | bone marrow | Q546523 |
P304 | page(s) | 273-81; quiz 282-4 | |
P577 | publication date | 1994-03-01 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Infections in bone marrow transplant recipients | |
P478 | volume | 18 |
Q40139928 | A cross-Canada survey of cytomegalovirus prevention and treatment practices in bone marrow transplant recipients |
Q40605329 | Aerobic bacterial and fungal infections in peripheral blood stem cell transplants |
Q40680644 | An autopsy study of systemic fungal infections in patients with hematologic malignancies |
Q45241091 | Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation |
Q35374928 | Antifungal prophylaxis during neutropenia and immunodeficiency |
Q33984369 | Cell wall-deficient bacteria as a cause of infections: a review of the clinical significance |
Q33937783 | Cell-wall-deficient bacteria and culture-negative febrile episodes in bone-marrow-transplant recipients |
Q34437719 | Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics |
Q73287023 | Comparison of commercially available antibody reagents for the cytomegalovirus pp65 antigenemia assay |
Q54125126 | Cutaneous manifestations of Paecilomyces lilacinus infection induced by a contaminated skin lotion in patients who are severely immunosuppressed. |
Q37039075 | Deficient Neutrophil Extracellular Trap Formation in Patients Undergoing Bone Marrow Transplantation |
Q39563927 | Detection of CMV DNA in bone marrow transplant recipients: plasma versus leucocyte polymerase chain reaction. |
Q41479520 | Differences in Aspergillus-specific immune recovery between T-cell-replete and T-cell-depleted hematopoietic transplants |
Q38189783 | Diffuse alveolar hemorrhage following allogeneic peripheral blood stem cell transplantation: a case report and a short review |
Q45184235 | Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis |
Q40569370 | Early infections in adult patients undergoing unrelated donor cord blood transplantation. |
Q39058080 | Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation |
Q44786516 | Fever in the immunocompromised host |
Q34490092 | Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? |
Q33608832 | Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology |
Q38178526 | Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients. |
Q28388806 | Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective |
Q36287958 | High-resolution computed tomography (HRCT) of lung infections in non-AIDS immunocompromised patients |
Q38285644 | Imaging of complications from hematopoietic stem cell transplant |
Q74319303 | Increasing the target number of nucleated cells and administration of r-metHuG-CSF expedite neutrophil engraftment in allogeneic bone marrow transplantation |
Q62241392 | Infección nosocomial en el paciente receptor de un trasplante de órgano sólido o de precursores hematopoyéticos |
Q39820778 | Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation. |
Q40590665 | Infectious complications in breast cancer patients undergoing peripheral blood stem cell transplantation: a single center retrospective analysis towards outpatient strategy |
Q38202579 | Infectious complications of stem cell transplantation |
Q30484888 | Introducing mediterranean journal of hematology and infectious diseases |
Q41557335 | Late infections following allogeneic bone marrow transplantation: suggested strategies for prophylaxis |
Q34520207 | Medullary allotransplant in acute myeloblastic leukemia in a child. |
Q46434311 | Mice lacking both G-CSF and IL-6 are more susceptible to Candida albicans infection: critical role of neutrophils in defense against Candida albicans |
Q34045440 | Monoclonal immunoglobulin G1 directed against Aspergillus fumigatus cell wall glycoprotein protects against experimental murine aspergillosis |
Q45107966 | Neutropenia and neoplasia: an overview of the pharmacoeconomics of sargramostim in cancer therapy |
Q40426131 | New and experimental therapies for treating graft-versus-host disease |
Q39505065 | Nosocomial infections in leukemic and solid-tumor cancer patients: distribution, outcome and microbial spectrum of anaerobes. |
Q43628076 | Pneumococcal infections in children after transplantation |
Q34121622 | Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation |
Q58573865 | Pulmonale Infektionen in der pädiatrischen Hämatologie und Onkologie |
Q35157722 | Pulmonary complications following bone marrow transplantation |
Q36268100 | Pulmonary complications following hematopoietic stem cell transplantation: diagnostic approaches |
Q38905025 | Pulmonary infiltrates in the cancer patient. New approaches to an old problem |
Q35072259 | Recommendations for immunizations in stem cell transplantation |
Q40658077 | Retrospective analysis of yeast colonization and infections in paediatric bone marrow transplant recipients |
Q58218038 | Risk Factors for Anaerobic Bloodstream Infections in Bone Marrow Transplant Recipients |
Q40619880 | Routine chest radiography for the evaluation of febrile neutropenic patients after autologous stem cell transplantation |
Q33763773 | The role of fibre-optic bronchoscopy in solid organ, transplant patients with pulmonary infections. |
Q33364468 | The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation |
Q35538579 | Thin-Section CT Findings in 32 Immunocompromised Patients with Cytomegalovirus Pneumonia Who Do Not Have AIDS |
Q41978755 | Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation |
Q73747937 | Vaccines for transplant recipients |
Q44146619 | Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients |
Search more.